Phase II study evaluating the impact of AXS-05 on smoking behavior.
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2017
At a glance
- Drugs Bupropion/dextromethorphan (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 21 Dec 2017 According to a Axsome Therapeutics media release, James M. Davis is the principal investigator for this trial.
- 21 Dec 2017 New trial record
- 14 Dec 2017 According to a Axsome Therapeutics media release, this trial is anticipated to initiate in the first quarter of 2018.